05/27/2025 5:09 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2025 7:56 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2025 8:41 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2025 6:20 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2025 10:23 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2025 8:53 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2025 8:15 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2025 8:38 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/01/2025 12:07 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/01/2025 10:44 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2025 11:38 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for AZN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter.
|
04/29/2025 11:22 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2025 6:55 PM | AstraZeneca (Subject) ASTRAZENECA PLC (Subject) BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
04/22/2025 5:37 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2025 12:40 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025 5:00 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject)
| Form SCHEDULE 13G/A | |
04/04/2025 5:43 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2025 5:06 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/01/2025 11:30 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025 6:16 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025 6:11 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2025 7:32 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025 6:17 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025 6:23 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025 6:30 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2025 2:33 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2025 9:23 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2025 6:17 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2025 6:20 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2025 5:31 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2025 10:06 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2025 9:52 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/03/2025 9:22 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/03/2025 5:00 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2025 8:29 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2025 5:08 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2025 5:59 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 9:30 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 7:02 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 6:49 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025 8:53 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
02/05/2025 11:15 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form EFFECT | |
02/03/2025 12:05 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/03/2025 5:23 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/28/2025 8:25 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/24/2025 8:52 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Cellectis S.A. (Subject)
| Form SCHEDULE 13D/A | |
01/21/2025 11:17 AM | AstraZeneca (Subject) ASTRAZENECA PLC (Subject) JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
| Form F-6 Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts | |
01/21/2025 5:40 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/17/2025 6:13 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2025 9:04 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2024 10:05 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/23/2024 11:13 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/16/2024 9:04 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2024 8:01 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024 9:28 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024 9:35 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/25/2024 5:43 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2024 10:15 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/18/2024 5:11 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024 8:13 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024 5:48 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024 11:31 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024 6:10 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2024 8:10 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2024 10:46 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024 8:38 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024 5:00 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Monopar Therapeutics (Subject)
| Form SC 13G | |
10/21/2024 8:48 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024 5:01 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject)
| Form SC 13G | |
10/07/2024 5:38 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/01/2024 9:45 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 5:42 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 5:44 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 5:27 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024 12:34 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024 5:21 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024 9:50 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 5:05 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2024 5:21 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024 9:11 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024 5:26 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024 5:00 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/26/2024 5:42 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2024 8:06 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024 5:15 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024 9:07 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024 5:07 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2024 4:00 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/25/2024 5:12 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024 5:07 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2024 5:38 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
White House to reset Social Security? (Ad) Elon Musk's parting DOGE gift looks set to shock America...
A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.  And it could have a major impact on how you collect Social Security - Click here to understand what' |
06/17/2024 5:21 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2024 9:14 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024 9:02 AM | AstraZeneca (Subject) ASTRAZENECA PLC (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
06/03/2024 9:23 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024 9:29 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024 5:35 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |